2023-05-09 20:49:03
Zurich (awp) – The eye care juggernaut Alcon posted an unexpected rate of growth in the first three months of the year. The ophthalmic surgery equipment manufacturer and contact lens producer subsequently raised its ambitions for the year as a whole.
Turnover was coated between January and the end of March by 7% to 2.33 billion dollars (2.07 billion Swiss francs), despite a decline of 6% to 427 million in implantable devices. All other business segments posted growth of more or less 10%.
The operating margin at group level improved by around twenty basis points (bp) to 11.5%. Stripped of any item deemed non-recurring, this indicator stagnated at 20.6%. Earnings per share gleaned a penny to 35 cents, according to a report released late Tuesday evening.
The performance blows the projections of analysts consulted by AWP, which capped revenue at 2.28 billion. The operating margin should only be 10.6% on average and that adjusted only 20.3%.
Management is still targeting sales for the current year as a whole of between 9.2 and 9.4 billion dollars, but the implicit growth excluding exchange rate effects should be between 7 and 9% at instead of 6 to 8%. Adjusted operating margin should still be between 19.5 and 20.5 percent and earnings per share between $2.55 and $2.65, but at the high end of that range.
jh/
1683691079
#Alcon #readjusts #target #1st #quarter
